Patient adherence to therapy after switch to aflibercept from bevacizumab or ranibizumab for treatment-refractory neovascular age-related macular degeneration by Simon D Archambault, Megan M Nichols, James C McCullum, Yubo Zhang, Elise E Steinberger, David J Ramsey

Get full text